Risk Factors for Flares and New Lesions of Hidradenitis Suppurativa Following COVID-19 Disease: A Retrospective Cohort Study of 310 Patients in Greece
COVID-19 may trigger HS flares and new onset, with biologic treatment and vaccination offering protection.
Authors
- Georgia Vrioni (ORCID: https://orcid.org/0000-0003-4766-8238)
- Eleni Chatzidimitriou (ORCID: https://orcid.org/0000-0002-1785-6601)
- Stefanos Bonovas (ORCID: https://orcid.org/0000-0001-6102-6579)
- George Samonis (ORCID: https://orcid.org/0000-0001-5857-9703)
- Efthymia Agiasofitou
- Andreas G. Tsantes (ORCID: https://orcid.org/0000-0002-3695-0759)
- Aikaterini Ι. Liakou (ORCID: https://orcid.org/0000-0003-3936-8374)
- Soultana Vladeni
- Konstantina A. Tsante (ORCID: https://orcid.org/0000-0002-2970-535X)
- Ourania Kotsafti (ORCID: https://orcid.org/0000-0003-4459-435X)
- Πέτρος Ιωάννου (ORCID: https://orcid.org/0000-0003-1082-5674)
- Magdalini Kalamata
- Angeliki Dragoutsou
- Evangelia‐Konstantina Bompou
- Alexander I. Stratigos
Institutions
- Humanitas University (IT)
- University of Crete (GR)
- National and Kapodistrian University of Athens (GR)
- St Savas Hospital (GR)
- Andreas Sygros Hospital (GR)
- University General Hospital Attikon (GR)
- Metropolitan Hospital (GR)
- IRCCS Humanitas Research Hospital (IT)
Publication Details
- Journal
- Microorganisms
- Published
- 2025-02-27
- DOI
- https://doi.org/10.3390/microorganisms13030542
- Citations
- 1
- Primary Topic
- Hidradenitis Suppurativa and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.00